Two cases of acute exacerbation of interstitial pneumonia treated with polymyxin B-immobilized fiber column hemoperfusion treatment.
The effect of polymixin B-immobilized fiber column (PMX) hemoperfusion treatment for acute exacerbation of interstitial pneumonia (IP) has been reported. Here, we report 2 cases of acute exacerbation of IP successfully treated with PMX hemoperfusion. One is a 55-year-old woman who was diagnosed as microscopic polyangiitis (MPA) with IP. The other is a 58-year-old man, diagnosed as having idiopathic pulmonary fibrosis. Both cases were treated with PMX hemoperfusion and other therapies. One died on day 44 and the other is still alive. The PMX hemoperfusion treatment decreased the serum levels of several cytokines and activated neutrophil percentage in bronchoalveolar lavage fluid.
Noma
Satoshi
S
Division of Respiratory Medicine, Respiratory and Stress Care Center, Kagoshima University Hospital.
Matsuyama
Wataru
W
Mitsuyama
Hideo
H
Suetsugu
Takayuki
T
Koreeda
Yoshimizu
Y
Mizuno
Keiko
K
Higashimoto
Ikkou
I
Kakihana
Yasuyuki
Y
Hashiguchi
Teruto
T
Maruyama
Ikuro
I
Osame
Mitsuhiro
M
Arimura
Kimiyoshi
K
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001992:Bronchoalveolar Lavage Fluid; D017809:Fatal Outcome; D005260:Female; D006464:Hemoperfusion / Q000379:methods*; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000150:complications / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011112:Polymyxin B / Q000627:therapeutic use*; D012131:Respiratory Insufficiency / Q000209:etiology / Q000628:therapy; D016896:Treatment Outcome